RAPT Therapeutics (RAPT)

RAPT Therapeutics (RAPT) Stock Price & Analysis


RAPT Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$15.59 - $31.45
Previous Close$18.31
Average Volume (3M)279.67K
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)$205.00M
Total Debt (Recent Filing)$8.00M
Price to Earnings (P/E)-6.8
Nov 09, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.70
Shares Outstanding34,358,152
10 Day Avg. Volume313,149
30 Day Avg. Volume279,672
Standard Deviation0.29
Financial Highlights & Ratios
Price to Book (P/B)3.29
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-5.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Price Target Upside93.88% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was RAPT Therapeutics’s price range in the past 12 months?
RAPT Therapeutics lowest stock price was $15.59 and its highest was $31.45 in the past 12 months.
    What is RAPT Therapeutics’s market cap?
    Currently, no data Available
    When is RAPT Therapeutics’s upcoming earnings report date?
    RAPT Therapeutics’s upcoming earnings report date is Nov 09, 2023 which is in 48 days.
      How were RAPT Therapeutics’s earnings last quarter?
      RAPT Therapeutics released its earnings results on Aug 11, 2023. The company reported -$0.66 earnings per share for the quarter, beating the consensus estimate of -$0.781 by $0.121.
        Is RAPT Therapeutics overvalued?
        According to Wall Street analysts RAPT Therapeutics’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does RAPT Therapeutics pay dividends?
          RAPT Therapeutics does not currently pay dividends.
          What is RAPT Therapeutics’s EPS estimate?
          RAPT Therapeutics’s EPS estimate is -$0.75.
            How many shares outstanding does RAPT Therapeutics have?
            RAPT Therapeutics has 34,358,150 shares outstanding.
              What happened to RAPT Therapeutics’s price movement after its last earnings report?
              RAPT Therapeutics reported an EPS of -$0.66 in its last earnings report, beating expectations of -$0.781. Following the earnings report the stock price went down -2.798%.
                Which hedge fund is a major shareholder of RAPT Therapeutics?
                Among the largest hedge funds holding RAPT Therapeutics’s share is Perceptive Advisors LLC. It holds RAPT Therapeutics’s shares valued at 43M.


                  RAPT Therapeutics Stock Smart Score

                  The RAPT Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  RAPT Therapeutics

                  Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company. It focuses on discovering, developing and commercializing oral small molecule therapies for patients in oncology and inflammatory diseases.. The company was founded in 2015 and is headquartered in South San Francisco, CA.


                  Top 5 ETFs holding RAPT

                  Market Value
                  Smart Score
                  Vanguard Total Stock Market ETF
                  Vanguard Health Care ETF
                  Schwab U.S. Broad Market ETF
                  iShares Russell 3000 ETF
                  Vanguard Russell 3000 ETF
                  Up to five ETFs with an Outperform Smart Score that hold RAPT. The ETFs are listed according to market value of RAPT within the ETF

                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Mirati Therapeutics
                  Bluebird Bio
                  Dianthus Therapeutics

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis